Commentary on Burns et al: MOUD saves lives, especially after 60 days, and the longer the better.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Demonstrating the potential for utilizing mobile methadone units to serve medically institutionalized populations in New York State.Journal of substance use and addiction treatment · 2026
   Article
2. Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder.Journal of addiction medicine · 2026
   Article
3. Cascade of Care for Opioid Use Disorder Among Medicaid Beneficiaries.JAMA network open · 2026
   Article
4. Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy.O&G open · 2026
   Article

Corrections and comments

• Comment on
  Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.2022

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as